Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00710749
What this trial is testing

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Who this might be right for
Bladder Outlet ObstructionLower Urinary Tract Symptoms
Wellspect HealthCare 60
Testing effectiveness (Phase 2)WithdrawnNCT00505258
What this trial is testing

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Who this might be right for
Bacteremia
Basilea Pharmaceutica
Not applicableLooking for participantsNCT07646171
What this trial is testing

EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)

Who this might be right for
Hormone Receptor Positive Breast Cancer
Tel-Aviv Sourasky Medical Center 19
Early research (Phase 1)WithdrawnNCT03905564
What this trial is testing

Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

Who this might be right for
Bioavailability
Grünenthal GmbH
Testing effectiveness (Phase 2)Study completedNCT01173172
What this trial is testing

Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Taipei Veterans General Hospital, Taiwan 17
Not applicableNot Yet RecruitingNCT07339098
What this trial is testing

Efficacy and Safety of the Ultrasound Stimulation Device NEFRONIX in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Anasonic 20
Not applicableStudy completedNCT01372462
What this trial is testing

Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Breathe Technologies, Inc. 15
Not applicableStudy completedNCT05050747
What this trial is testing

Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle

Who this might be right for
Female Infertility
Wael Elbanna Clinic 402
Not applicableNot Yet RecruitingNCT06162273
What this trial is testing

An Exploratory Study of Iliac Artery Branch Stent for Internal Iliac Artery Reconstruction in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair

Who this might be right for
Aortic Aneurysm, AbdominalIliac Aneurysm
RenJi Hospital 40
Large-scale testing (Phase 3)Study completedNCT05425719
What this trial is testing

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Who this might be right for
Chronic Kidney Disease
MediBeacon 249
Not applicableEnded earlyNCT02791451
What this trial is testing

Predicting Exacerbation of COPD With Wireless Telemonitoring

Who this might be right for
COPD
Turku University Hospital 6
Large-scale testing (Phase 3)Study completedNCT00719472
What this trial is testing

Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)

Who this might be right for
Non-Hodgkin's Lymphoma
Genentech, Inc. 451
Not applicableLooking for participantsNCT06469736
What this trial is testing

Comparison Between Ureterorenoscopy With Lithotripsy Alone Versus Combination With Hydrogel for Kidney Stone Removal

Who this might be right for
NephrolithiasisLithotripsy, LaserUreteroscopy
Technical University of Munich 120
Testing effectiveness (Phase 2)Looking for participantsNCT06134232
What this trial is testing

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Dendreon 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT07346235
What this trial is testing

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Who this might be right for
Infertility, Female
American Hospital 2 Kosovo 440
Post-approval studies (Phase 4)Study completedNCT02219412
What this trial is testing

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

Who this might be right for
Coronary Heart Disease
Yong Huo 70
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Early research (Phase 1)Ended earlyNCT01240642
What this trial is testing

An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404

Who this might be right for
Metastatic Cancer With Impaired Renal FunctionMetastatic Cancer With Normal Renal Function
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Study completedNCT02543255
What this trial is testing

Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Who this might be right for
Prostate Cancer
University Health Network, Toronto 76
Next Page